Alliance for Clinical Trials in Oncology: Multiple Myeloma trials
The registry lists 18 Multiple Myeloma studies with Alliance for Clinical Trials in Oncology as lead sponsor. 1 are open to participants now and 5 have results posted.
Phase 1 5Phase 2 8Phase 3 7No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Comparing Bispecific Antibody Treatment to Autologous Stem Cell Transplant for Newly Diagnosed, Standard Risk Multiple MyelomaNot yet recruitingNCT07887984Phase 2/3
- Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple MyelomaActive, not recruitingNCT02004275Phase 1/2Results posted
- Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell TransplantTerminatedNCT01118013Phase 2Results posted
- Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementCompletedNCT00869206Phase 3Results posted
- American Ginseng in Treating Patients With Fatigue Caused by CancerCompletedNCT00719563Phase 3Results posted
- Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With CancerCompletedNCT00516503Phase 3Results posted
- Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple MyelomaSuspendedNCT06232044Phase 1/2
- Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple MyelomaCompletedNCT03870633
- Collection of Patient-Reported Symptoms and Performance Status Via the InternetCompletedNCT00417040Not applicable
- Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerWithdrawnNCT00085449Phase 1/2
- Epoetin Alfa in Treating Anemia in Patients With Solid TumorsCompletedNCT00058331Phase 3
- Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic CancerCompletedNCT00053196Phase 2
- Cytogenetic Studies in Acute Leukemia and Multiple MyelomaActive, not recruitingNCT00048958
- Peripheral Stem Cell Transplant in Treating Patients With Multiple MyelomaCompletedNCT00028600Phase 2
- Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer TreatmentCompletedNCT00006348Phase 3
- 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver ImpairmentTerminatedNCT00004239Phase 1
- Epoetin Alfa in Treating Anemia in Patients Who Are Receiving ChemotherapyCompletedNCT00003600Phase 3
- Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight LossCompletedNCT00003077Phase 1/2